Bromotiacumicin compounds
    9.
    发明授权
    Bromotiacumicin compounds 失效
    溴菊酯化合物

    公开(公告)号:US5767096A

    公开(公告)日:1998-06-16

    申请号:US678906

    申请日:1996-07-12

    CPC分类号: C07H17/08

    摘要: Antimicrobial compounds having the formula ##STR1## wherein R.sup.1 and R.sup.2 are independently selected from the group consisting of hydrogen and C.sub.1 -to-C.sub.4 alkanoyl; R.sup.3 and R.sup.4 are selected from the group consisting of (a) R.sup.3 is hydrogen and R.sup.4 is hydroxy, (b) R.sup.3 is hydroxy and R.sup.4 is hydrogen, (c) R.sup.3 and R.sup.4 taken together are .dbd.O; or selected from the group consisting of hydrogen and hydroxy; and R.sup.5 and R.sup.6 are independently selected from the group consisting of hydrogen, bromine and chlorine, with the proviso that at least one of R.sup.5 and R.sup.6 must be bromine. Also disclosed are pharmaceutical compositions comprising such compounds, methods of treating bacterial infection by the administration thereof and a process for preparing said compounds.

    摘要翻译: 具有式“IMAGE”的抗微生物化合物,其中R 1和R 2独立地选自氢和C 1 -C 4烷酰基; R3和R4选自(a)R3是氢,R4是羟基,(b)R3是羟基,R4是氢,(c)R3和R4一起是= O; 或选自氢和羟基; 并且R 5和R 6独立地选自氢,溴和氯,条件是R 5和R 6中的至少一个必须是溴。 还公开了包含这些化合物的药物组合物,通过其给药治疗细菌感染的方法和制备所述化合物的方法。

    Farnesyl dibenzodiazepinone, and processes for its production
    10.
    发明授权
    Farnesyl dibenzodiazepinone, and processes for its production 有权
    法呢基二苯并二氮杂酮及其制备方法

    公开(公告)号:US07101872B2

    公开(公告)日:2006-09-05

    申请号:US10762107

    申请日:2004-01-21

    IPC分类号: C07D243/10 A61K31/55

    摘要: This invention relates to a novel farnesylated dibenzodiazepinone, named ECO-04601, its pharmaceutically acceptable salts and derivatives, and to methods for obtaining such compounds. One method of obtaining the ECO-04601 compound is by cultivation of a novel strain of Micromonospora sp., 046-ECO11; another method involves expression of biosynthetic pathway genes in transformed host cells. The present invention further relates to Micromonospora sp. strain 046-ECO11, to the use of ECO-04601 and its pharmaceutically acceptable salts and derivatives as pharmaceuticals, in particular to their use as inhibitors of cancer cell growth, bacterial cell growth, mammalian lipoxygenase, and to pharmaceutical compositions comprising ECO-04601 or a pharmaceutically acceptable salt or derivative thereof. Finally, the invention relates to novel polynucleotide sequences and their encoded proteins, which are involved in the biosynthesis of ECO-04601.

    摘要翻译: 本发明涉及名为ECO-04601的新型法呢基化二苯并二氮杂酮,其药学上可接受的盐和衍生物,以及获得这些化合物的方法。 获得ECO-04601化合物的一种方法是通过培养一种新型的小单孢菌属菌株046-ECO11; 另一种方法涉及在转化的宿主细胞中表达生物合成途径基因。 本发明还涉及小单孢菌属 应用046-ECO11,使用ECO-04601及其药学上可接受的盐和衍生物作为药物,特别是其作为癌细胞生长抑制剂,细菌细胞生长,哺乳动物脂氧合酶的用途,以及包含ECO-04601或 其药学上可接受的盐或衍生物。 最后,本发明涉及参与ECO-04601的生物合成的新型多核苷酸序列及其编码的蛋白质。